ArticleFrontiers in oncology2019
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma.
Ann W Silk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papertrialcites it
ArticleFrontiers in oncology2019
Ann W Silk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.